科技奖项：
2004年 体脂、胰岛素抵抗与代谢综合征关系的研究 国家科技进步奖 二等奖
2009年 2型糖尿病的发病机理和临床诊治技术 国家科技进步奖 二等奖
2011年 糖尿病血糖监测新技术的开发和临床应用 上海市科技进步奖 一等奖
2012年 糖尿病早期预警的R列研究及临床应用 高等学校科学研究优秀成果奖科学技术进步奖  一等奖
2013年 2型糖尿病遗传机制新发现与早期预警标记的系列研究和临床应用 上海市科技进步奖 一等奖

重要论文：
1. Jia W*, Xiao X, Ji Q, Ahn KJ, Chuang LM, Bao Y, Pang C, Chen L, Gao F, Tu Y, Li P, Yang J. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial, Lancet Diabetes Endocrinol. 2015, 3(4): 254-62. (IF=16.32，被引20次)
2. Bao Y, Ma X, Li H, Zhou M, Hu C, Wu H, Tang J, Hou X, Xiang K, Jia W*. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ. 2010, 340: c2249. (IF=13.471，被引124次)
3. Lu J, Ma X, Zhou J*, Zhang L, Mo Y, Ying L, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W*. Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care. 2018,41(11):2370-2376. (IF=13.397，被引3次)
4. Yan J, Peng D, Jiang F, Zhang R, Chen M, Wang T, Yan D, Wang S, Hou X, Bao Y, Hu C*, Jia W*. Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population. Diabetologia. 2016;59(7):1458-1462. (IF=6.206，被引9次)
5. Li H, Wu G, Fang Q, Zhang M, Hui X, Sheng B, Wu L, Bao Y, Li P, Xu A, Jia W*. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Nat Commun. 2018 Jan 18;9(1):272. (IF=12.124，被引21次)